Download PDF
Aktuelle Rheumatologie 2013; 38(05): 294-299
DOI: 10.1055/s-0032-1323826
Übersichtsarbeit
© Georg Thieme Verlag KG Stuttgart · New York

Kutane leukozytoklastische Vaskulitis, Purpura Schönlein-Henoch und kryoglobulinämische Vaskulitis

Cutaneous Leukocytoclastic Vasculitis, Henoch-Schönlein Purpura and Cryoglobulinemic Vasculitis
S. I. Unger
1   Medizinische Klinik II, Sektion Rheumatologie, Universitätsklinikum Leipzig, Leipzig
,
C. Baerwald
1   Medizinische Klinik II, Sektion Rheumatologie, Universitätsklinikum Leipzig, Leipzig
› Author Affiliations
Further Information

Publication History

Publication Date:
18 October 2012 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die leukozytoklastische Vaskulitis, Purpura Schönlein-Henoch und kryoglobulinämische Vaskulitis sind Immunkomplexvaskulitiden, die sich durch Ablagerung verschiedener Immunglobuline in den kleinen Gefäßen unterscheiden und sich meist als palpable Purpura klinisch manifestieren. Die differenzialdiagnostische Abgrenzung und die Unterscheidung der primären von sekundären Formen stellt eine Herausforderung für Rheumatologen dar. Die frühzeitige Detektion extrakutaner Organmanifestationen wie Glomerulonephritis, mesenteriale Vaskulitis oder periphere Neuropathie ist für die Therapieindikation und damit die Prognose der Kleingefäßvaskulitiden essentiell.

Abstract

Leukocytoclastic vasculitis, Henoch-Schönlein purpura, cryoglobulinemic vasculitis are defined as immune complex vasculitides and are mediated by deposition of different immunoglobulins in small vessels. Palpable purpura is the most common symptom. Differentiation of the three immune complex vasculitides and secondary forms of vasculitis is challenging for rheumatologists. Early detection of extracutaneous manifestations like glomerulonephritis, mesenterial vasculitis or peripheral neuropathy is essential to initiate appropriate treatment strategies and thereby influencing the prognosis of small-vessel vasculitides.

Schlüsselwörter

leukozytoklastische Vaskulitis - Kleingefäßvaskulitis - Purpura Schönlein-Henoch - Kryoglobulinämie

Key words

leukocytoclastic vasculitis - small-vessel vasculitis - Henoch-Schönlein purpura - cryoglobulinaemia
 

  • Literatur

  • 1 Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192
    CrossrefPubMedGoogle Scholar
  • 2 Braun GS, Horster S, Wagner KS et al. Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects. Postgrad Med J 2007; 83: 87-94
    CrossrefPubMedGoogle Scholar
  • 3 Hospach T, Huppertz HI. Purpura Schönlein-Henoch. Z Rheumatol 2011; 70: 829-837
    CrossrefPubMedGoogle Scholar
  • 4 Russell JP, Gibson LE. Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment. Int J Dermatol 2006; 45 (01) 3-13
    CrossrefPubMedGoogle Scholar
  • 5 Sunderkötter C, Roth J, Bonsmann G. Leukocytoclastic vasculitis. Hautarzt 2004; 55 (08) 759-783
    PubMedGoogle Scholar
  • 6 Sunderkötter C, Bonsmann G, Sindrilaru A et al. Management of leukocytoclastic vasculitis. J Dermatolog Treat 2005; 16 (04) 193-206
    CrossrefPubMedGoogle Scholar
  • 7 Roberts PF, Waller TA, Brinker TM et al. Henoch-Schönlein Purpura: A Review Article. Southern Medical Journal 2007; 100: 821-824
    CrossrefPubMedGoogle Scholar
  • 8 Huppertz HI. Purpura Schönlein-Henoch. Monatsschr Kinderheilkd 2006; 154: 865-871
    CrossrefPubMedGoogle Scholar
  • 9 Tedeschi A, Barate C, Minola E et al. Cryoglobulinemia. Blood Reviews 2007; 21: 183-200
    CrossrefPubMedGoogle Scholar
  • 10 Unger S, Baerwald C. Leukocytoclastic vasculitis. arthritis+rheuma 2010; 30: 205-210
    PubMedGoogle Scholar
  • 11 Sohagia AB, Gunturu SG, Tong TR et al. Henoch-Schonlein Purpura-A case report and review of the literature. Gastroenterol Res Pract. 2010 2010. 597-648
    PubMedGoogle Scholar
  • 12 Jessop SJ. Cutaneous leukocytoclastic vasculitis: a clinical and aetiological study. Br J Rheumatol 1995; 34: 942-945
    CrossrefPubMedGoogle Scholar
  • 13 Somer T, Finegold SM. Vasculitides associated with infections, immunization, and antimicrobial drugs. Clin Infect Dis 1995; 20: 1010-1036
    CrossrefPubMedGoogle Scholar
  • 14 ten Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother 2002; 36: 130-147
    CrossrefPubMedGoogle Scholar
  • 15 Ramos-Casals M, Stone JH, Cid MC et al. The cryoglobulinaemias. Lancet 2012; 379: 348-360
    CrossrefPubMedGoogle Scholar
  • 16 Trejo O, Ramos-Casals M, Garcia-Carrasco M et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 2001; 80: 252-262
    CrossrefPubMedGoogle Scholar
  • 17 Brouet JC, Clauvel JP, Danon F et al. Biological and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57: 775-788
    CrossrefPubMedGoogle Scholar
  • 18 Dammacco F, Sansonno D, Piccoli C et al. The cryoglobulins an overview. Eur J Clin Invest 2001; 31: 628-638
    CrossrefPubMedGoogle Scholar
  • 19 Rosa D, Saletti G De Gregorio et al. Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA 2005; 102: 18544-18549
    CrossrefPubMedGoogle Scholar
  • 20 Kayali Z, Buckwold VE, Zimmermann B et al. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 2002; 36: 978-985
    PubMedGoogle Scholar
  • 21 Saadoun D, Asselak T, Resche-Rigon M et al. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C. Hepatology 2006; 43: 1337-1345
    CrossrefPubMedGoogle Scholar
  • 22 Ferri C, La Civita L, Cirafisi C et al. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. J Rheumatol 1992; 19 (06) 889-895
    PubMedGoogle Scholar
  • 23 Ferri C, Sebastiani M, Giuggioli D et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 321 patients. Seminars Arthritis and Rheumatism 2004; 33: 355-374
    PubMedGoogle Scholar
  • 24 Invernizzi F, Pietrogrande M, Sagramoso B. Classification of the cryoglobulinemic syndrome. Clin Exp Rheumatol 1995; 13 (Suppl. 13) 123
    PubMedGoogle Scholar
  • 25 Mukhtyar C, Guillevin L, Cid MC et al. EULAR Recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009; 68 (03) 310-317
    CrossrefPubMedGoogle Scholar
  • 26 Cacoub P, Saadoun D, Limal N et al. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2005; 52: 911-915
    CrossrefPubMedGoogle Scholar
  • 27 Saadoun D, Resche-Rigon M, Thibault V et al. Antiviral therapy for hepatitis C virus associated mixed cryoglobulinemia vasculitis: a long-term follow-up study. Arthritis Rheum 2006; 54: 3696-3706
    CrossrefPubMedGoogle Scholar
  • 28 Callen JP, Ekenstam E. Cutaneous leukocytoclastic vasculitis: clinical experience in 44 patients. South Med J 1987; 80: 848-851
    CrossrefPubMedGoogle Scholar
  • 29 Pyne D, Mootoo R, Bhanji A. Colchicine for the treatment of recurrent Henoch-Schonlein Purpura in an adult. Rheumatology (Oxford) 2001; 40: 1430-1431
    CrossrefPubMedGoogle Scholar
  • 30 Ruiz Villaverde R, Blasco Melguizo J, Martin Sanchez MC et al. Annular leukocytoclastic vasculitis: response to dapsone. J Eur Acad Dermatol Venereol 2002; 16: 544-546
    CrossrefPubMedGoogle Scholar
  • 31 Mahr A, Chaigne-Delalande S, De Menthon M. Therapeutic plasma exchange in systemic vasculitis: an update on indications and results. Curr Opin Rheumatol 2012; 24 (03) 261-266
    CrossrefPubMedGoogle Scholar
  • 32 Chandesris MO, Gayet S, Schleinitz N et al. Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia. Rheumatology (Oxford) 2004; 43: 532-533
    CrossrefPubMedGoogle Scholar
  • 33 Dede F, Onec B, Ayli D et al. Mycophenolate mofetil treatment of crescentic Henoch-Schönlein nephritis with IgA depositions. Scand J Urol Nephrol 2008; 42 (02) 178-180
    PubMedGoogle Scholar
  • 34 Nikibakhsh AA, Mahmoodzadeh H, Karamyyar M et al. Treatment of complicated Henoch-Schönlein purpura with mycophenolate mofetil: a retrospective case series report. Int J Rheumatol. 2010 2010. 254-316
    PubMedGoogle Scholar
  • 35 Uthman IW, Touma Z, Sayyad J et al. Response of deep cutaneous vasculitis to infliximab. J Am Acad Dermatol 2005; 53: 353-354
    CrossrefPubMedGoogle Scholar
  • 36 Bryce AH, Dispenzieri A, Kyle RA et al. Response to rituximab in patients with type II cryoglobulinemia. Clin Lymphoma Myeloma 2006; 7: 140-144
    CrossrefPubMedGoogle Scholar
  • 37 De Vita S, Quartuccio L, Isola M et al. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 2012; 64 (03) 843-853
    CrossrefPubMedGoogle Scholar
  • 38 Ferri C, Cacoub P, Mazzaro C et al. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev 2011; 11 (01) 48-55
    CrossrefPubMedGoogle Scholar
  • 39 Lamprecht P, Lerin-Lozano C, Merz H et al. Rituximab induces remission in HCV-associated cryoglobulinemic vasculitis. Ann Rheum Dis 2003; 62: 1230-1233
    CrossrefPubMedGoogle Scholar
  • 40 Quartuccio L, Soardo G, Romano G et al. Rituximab treatment for glomerulonephritis in HCV associated mixed cryoglobulinemia: efficacy and safety in the absence of steroids. Rheumatology 2006; 45: 842-846
    CrossrefPubMedGoogle Scholar
  • 41 Sneller MC, Hu Z, Langford CA. A randomized controlled trail of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis. Arthritis Rheum 2012; 64 (03) 835-842
    CrossrefPubMedGoogle Scholar
  • 42 Zaja F, De Vita S, Mazzaro C et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 2003; 101: 3827-3834
    CrossrefPubMedGoogle Scholar
  • 43 Mohan N, Edwards ET, Cupps TR et al. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol 2004; 31: 1955-1958
    PubMedGoogle Scholar
  • 44 Trendelenburg M, Fossati-Jimack I, Cortes-Hernandez J et al. The role of complement in cryoglobulin-induced immune complex glomerulonephritis. J Immunol 2005; 175: 6909-6914
    PubMedGoogle Scholar